“…The integration of data from genomics (polymorphisms and other structural genetic variants), epigenomics (DNA methylation, histone modifications, telomere length), metagenomics (gut microbiota composition, enterotypes), transcriptomics (gene expression patterns), proteomics (protein expression and modification patterns), and metabolomics (metabolite pattern) have given rise to the identification of some potential molecular targets and active biomarkers involved in many nutritional disorders (including obesity, dyslipidemias, fatty liver, insulin resistance), inflammation, cardiovascular diseases and cancer [ 59 ]. Studies focused on the influence of nutrition on epigenetic mechanisms, such as changes (reversible) in DNA methylation and histone modifications are particularly promising for cancer prevention, since epigenetic abnormalities may occur at a very early stage during neoplastic transformation [ 60 ]. Interestingly, recent reports suggest that miRNAs (small non-coding RNAs which regulate gene and protein expression), are able to mediate the interaction between dietary regimens and a variety of molecular pathways, in both physiological and pathological conditions [ 61 – 64 ].…”